In non-alcoholic fatty liver disease patients, a meta-analysis indicated that elevated CK-18 levels might be beneficial for identifying non-alcoholic steatohepatitis and fibrosis, particularly for M65 [36]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.